5:58 PM
 | 
Aug 27, 2014
 |  BC Extra  |  Financial News

Bellicum secures $55 million in series C

Bellicum Pharmaceuticals Inc. (Houston, Texas) secured $55 million in a series C round from 11 new investors, including RA Capital; Perceptive Advisors; Jennison Associates; Sabby Capital; Ridgeback Capital Management; venBio Select; Redmile Group; and AJU...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >